Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AXSM vs $ELAN | Chartloom

Compare

$AXSM vs $ELAN

Axsome Therapeutics Inc · Elanco Animal Health Inc

AXSM

Axsome Therapeutics Inc

ELAN

Elanco Animal Health Inc

Compare $AXSM vs $ELAN

Comparing Axsome Therapeutics Inc and Elanco Animal Health Inc

AXSMAxsome Therapeutics Inc

ELANElanco Animal Health Inc

AXSMAxsome Therapeutics Inc

Market cap

$8.04B

P/E (TTM)

—

Forward P/E (NTM)

211.90x

Forward P/S (NTM)

6.58x

Rev growth (TTM)

56.9%

YTD performance

-12.5%

52W performance

28.4%

FCF yield

-0.9%

ELANElanco Animal Health Inc

Market cap

$11.19B

P/E (TTM)

—

Forward P/E (NTM)

18.48x

Forward P/S (NTM)

2.09x

Rev growth (TTM)

12.0%

YTD performance

-0.5%

52W performance

13.4%

FCF yield

3.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AXSM

ELAN

Detailed metrics comparison

AXSM

Axsome Therapeutics Inc

ELAN

Elanco Animal Health Inc

Market Cap

AXSM$8.04B

ELAN$11.19B

Enterprise Value

AXSM$7.93B

ELAN$14.58B

Price

AXSM$156.32

ELAN$22.41

P/E Ratio

AXSMN/A

ELANN/A

P/S Ratio

AXSM10.36x

ELAN2.23x

EV/Sales

AXSM10.21x

ELAN2.90x

EV/EBITDA

AXSM0.00x

ELAN14.20x

P/B Ratio

AXSM105.86x

ELAN1.74x

P/FCF Ratio

AXSMN/A

ELAN29.53x

EV/FCF

AXSM-110.16x

ELAN38.47x

PEG Ratio

AXSMN/A

ELANN/A

Forward P/E (NTM)

AXSM211.90x

ELAN18.48x

Forward P/S (NTM)

AXSM6.58x

ELAN2.09x

Revenue (TTM)

AXSM$777M

ELAN$5.02B

Revenue Growth (YoY)

AXSM56.9%

ELAN12.0%

Forward Rev Growth

AXSM59.9%

ELAN5.4%

Gross Margin (TTM)

AXSM93.2%

ELAN55.4%

Operating Margin (TTM)

AXSM0.0%

ELAN0.0%

EBITDA Margin (TTM)

AXSM-23.0%

ELAN20.4%

Net Margin (TTM)

AXSM-24.7%

ELAN-4.0%

FCF Margin (TTM)

AXSM-9.3%

ELAN7.5%

Net Income (TTM)

AXSM$-192M

ELAN$-199M

FCF (TTM)

AXSM$-72M

ELAN$379M

EPS (TTM)

AXSM-$3.70

ELAN-$0.39

ROE (TTM)

AXSM-25560.0%

ELAN-302.0%

ROA (TTM)

AXSM-2705.0%

ELAN-148.0%

ROIC (TTM)

AXSM-7042.0%

ELAN-188.0%

Cash

AXSM$320M

ELAN$530M

Debt

AXSM$202M

ELAN$3.92B

Net Cash/Debt

AXSM$117M

ELAN$-3.39B

Current Ratio (TTM)

AXSM1.43x

ELAN2.05x

Quick Ratio (TTM)

AXSM1.30x

ELAN0.91x

Debt/Equity (TTM)

AXSM2.43x

ELAN0.59x

Debt/Assets (TTM)

AXSM0.0%

ELAN0.0%

Interest Coverage (TTM)

AXSMN/A

ELANN/A

Net Debt/EBITDA (TTM)

AXSM0.00x

ELAN0.00x

Beta

AXSM0.79

ELAN1.75

52W Performance

AXSM28.4%

ELAN13.4%

YTD Performance

AXSM-12.5%

ELAN-0.5%

% from 52W High

AXSM-39.9%

ELAN-19.9%

% from 52W Low

AXSM31.1%

ELAN15.5%

Asset Turnover (TTM)

AXSM1.10x

ELAN0.37x

FCF Yield (TTM)

AXSM-0.9%

ELAN3.4%

Earnings Yield (TTM)

AXSM-2.4%

ELAN-1.8%

Dividend Yield (TTM)

AXSMN/A

ELANN/A

Rule of 40

AXSM47.6

ELAN19.5

EV/GP/RG

AXSM0.19

ELAN0.76

Ticker research

View AXSM research View ELAN research

Metric	AXSM Axsome Therapeutics Inc	ELAN Elanco Animal Health Inc
Market & Valuation
Market Cap	$8.04B	$11.19B
Enterprise Value	$7.93B	$14.58B
Price	$156.32	$22.41
P/E Ratio	N/A	N/A
P/S Ratio	10.36x	2.23x
EV/Sales	10.21x	2.90x
EV/EBITDA	0.00x	14.20x
P/B Ratio	105.86x	1.74x
P/FCF Ratio	N/A	29.53x
EV/FCF	-110.16x	38.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	211.90x	18.48x
Forward P/S (NTM)	6.58x	2.09x
Revenue & Growth
Revenue (TTM)	$777M	$5.02B
Revenue Growth (YoY)	56.9%	12.0%
Forward Rev Growth	59.9%	5.4%
Profitability
Gross Margin (TTM)	93.2%	55.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-23.0%	20.4%
Net Margin (TTM)	-24.7%	-4.0%
FCF Margin (TTM)	-9.3%	7.5%
Net Income (TTM)	$-192M	$-199M
FCF (TTM)	$-72M	$379M
EPS (TTM)	-$3.70	-$0.39
ROE (TTM)	-25560.0%	-302.0%
ROA (TTM)	-2705.0%	-148.0%
ROIC (TTM)	-7042.0%	-188.0%
Financial Health
Cash	$320M	$530M
Debt	$202M	$3.92B
Net Cash/Debt	$117M	$-3.39B
Current Ratio (TTM)	1.43x	2.05x
Quick Ratio (TTM)	1.30x	0.91x
Debt/Equity (TTM)	2.43x	0.59x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.79	1.75
52W Performance	28.4%	13.4%
YTD Performance	-12.5%	-0.5%
% from 52W High	-39.9%	-19.9%
% from 52W Low	31.1%	15.5%
Efficiency & Yields
Asset Turnover (TTM)	1.10x	0.37x
FCF Yield (TTM)	-0.9%	3.4%
Earnings Yield (TTM)	-2.4%	-1.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	47.6	19.5
EV/GP/RG	0.19	0.76
Ticker research	View AXSM research	View ELAN research

Valuation

P/S Ratio

ELAN

2.23x

AXSM

10.36x

EV/FCF

AXSM

-110.16x

ELAN

38.47x

Growth & revenue

Revenue Growth TTM

AXSM

56.9%

ELAN

12.0%

Forward Revenue Growth

AXSM

59.9%

ELAN

5.4%

Profitability & performance

Gross Margin

AXSM

93.2%

ELAN

55.4%

ROE

ELAN

-302.0%

AXSM

-25560.0%

FCF Yield %

ELAN

3.4%

AXSM

-0.9%

52-Week Performance

AXSM

28.4%

ELAN

13.4%

Detailed metrics comparison

AXSM

Axsome Therapeutics Inc

ELAN

Elanco Animal Health Inc

Market Cap

AXSM$8.04B

ELAN$11.19B

Enterprise Value

AXSM$7.93B

ELAN$14.58B

Price

AXSM$156.32

ELAN$22.41

P/E Ratio

AXSMN/A

ELANN/A

P/S Ratio

AXSM10.36x

ELAN2.23x

EV/Sales

AXSM10.21x

ELAN2.90x

EV/EBITDA

AXSM0.00x

ELAN14.20x

P/B Ratio

AXSM105.86x

ELAN1.74x

P/FCF Ratio

AXSMN/A

ELAN29.53x

EV/FCF

AXSM-110.16x

ELAN38.47x

PEG Ratio

AXSMN/A

ELANN/A

Forward P/E (NTM)

AXSM211.90x

ELAN18.48x

Forward P/S (NTM)

AXSM6.58x

ELAN2.09x

Revenue (TTM)

AXSM$777M

ELAN$5.02B

Revenue Growth (YoY)

AXSM56.9%

ELAN12.0%

Forward Rev Growth

AXSM59.9%

ELAN5.4%

Gross Margin (TTM)

AXSM93.2%

ELAN55.4%

Operating Margin (TTM)

AXSM0.0%

ELAN0.0%

EBITDA Margin (TTM)

AXSM-23.0%

ELAN20.4%

Net Margin (TTM)

AXSM-24.7%

ELAN-4.0%

FCF Margin (TTM)

AXSM-9.3%

ELAN7.5%

Net Income (TTM)

AXSM$-192M

ELAN$-199M

FCF (TTM)

AXSM$-72M

ELAN$379M

EPS (TTM)

AXSM-$3.70

ELAN-$0.39

ROE (TTM)

AXSM-25560.0%

ELAN-302.0%

ROA (TTM)

AXSM-2705.0%

ELAN-148.0%

ROIC (TTM)

AXSM-7042.0%

ELAN-188.0%

Cash

AXSM$320M

ELAN$530M

Debt

AXSM$202M

ELAN$3.92B

Net Cash/Debt

AXSM$117M

ELAN$-3.39B

Current Ratio (TTM)

AXSM1.43x

ELAN2.05x

Quick Ratio (TTM)

AXSM1.30x

ELAN0.91x

Debt/Equity (TTM)

AXSM2.43x

ELAN0.59x

Debt/Assets (TTM)

AXSM0.0%

ELAN0.0%

Interest Coverage (TTM)

AXSMN/A

ELANN/A

Net Debt/EBITDA (TTM)

AXSM0.00x

ELAN0.00x

Beta

AXSM0.79

ELAN1.75

52W Performance

AXSM28.4%

ELAN13.4%

YTD Performance

AXSM-12.5%

ELAN-0.5%

% from 52W High

AXSM-39.9%

ELAN-19.9%

% from 52W Low

AXSM31.1%

ELAN15.5%

Asset Turnover (TTM)

AXSM1.10x

ELAN0.37x

FCF Yield (TTM)

AXSM-0.9%

ELAN3.4%

Earnings Yield (TTM)

AXSM-2.4%

ELAN-1.8%

Dividend Yield (TTM)

AXSMN/A

ELANN/A

Rule of 40

AXSM47.6

ELAN19.5

EV/GP/RG

AXSM0.19

ELAN0.76

Ticker research

View AXSM research View ELAN research

Metric	AXSM Axsome Therapeutics Inc	ELAN Elanco Animal Health Inc
Market & Valuation
Market Cap	$8.04B	$11.19B
Enterprise Value	$7.93B	$14.58B
Price	$156.32	$22.41
P/E Ratio	N/A	N/A
P/S Ratio	10.36x	2.23x
EV/Sales	10.21x	2.90x
EV/EBITDA	0.00x	14.20x
P/B Ratio	105.86x	1.74x
P/FCF Ratio	N/A	29.53x
EV/FCF	-110.16x	38.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	211.90x	18.48x
Forward P/S (NTM)	6.58x	2.09x
Revenue & Growth
Revenue (TTM)	$777M	$5.02B
Revenue Growth (YoY)	56.9%	12.0%
Forward Rev Growth	59.9%	5.4%
Profitability
Gross Margin (TTM)	93.2%	55.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-23.0%	20.4%
Net Margin (TTM)	-24.7%	-4.0%
FCF Margin (TTM)	-9.3%	7.5%
Net Income (TTM)	$-192M	$-199M
FCF (TTM)	$-72M	$379M
EPS (TTM)	-$3.70	-$0.39
ROE (TTM)	-25560.0%	-302.0%
ROA (TTM)	-2705.0%	-148.0%
ROIC (TTM)	-7042.0%	-188.0%
Financial Health
Cash	$320M	$530M
Debt	$202M	$3.92B
Net Cash/Debt	$117M	$-3.39B
Current Ratio (TTM)	1.43x	2.05x
Quick Ratio (TTM)	1.30x	0.91x
Debt/Equity (TTM)	2.43x	0.59x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.79	1.75
52W Performance	28.4%	13.4%
YTD Performance	-12.5%	-0.5%
% from 52W High	-39.9%	-19.9%
% from 52W Low	31.1%	15.5%
Efficiency & Yields
Asset Turnover (TTM)	1.10x	0.37x
FCF Yield (TTM)	-0.9%	3.4%
Earnings Yield (TTM)	-2.4%	-1.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	47.6	19.5
EV/GP/RG	0.19	0.76
Ticker research	View AXSM research	View ELAN research